Rare disease and gene therapy stocks, battered in recent months by clinical and commercial setbacks, will likely benefit from the sudden departure this past week of Vinayak (Vinay) Prasad, MD, as ...

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

The study links aging organisms' inability to sustain production of key proteins to impaired translation and increased ...

These soluble protein agonists can replicate Notch activation in suspension culture, opening the door to scalable T-cell therapies.

The Waltham Innovation Center will complement Aldevron’s established scientific teams in Fargo, ND, and Madison, WI.

Stem cells differentiated into brain and neural organoids may help scientists understand both brain development and ...

DEK will provide essential infrastructure and expertise to support Bio Usawa's market entry and expansion across West Africa.

The data shows that RORDEP-proteins boost the production of hormones like GLP-1 and PYY, which help regulate appetite and ...

Targeted rewriting of the epigenome promises to overcome several challenges in direct gene editing in patient therapies.

Improved understanding of how bacterial defense mechanisms operate may help scientists select phages with the best chance of ...

They’ve developed an AI-driven “Virtual Lab,” through which a team of AI agents, each equipped with varied scientific ...

OpenCRISPR-1, an AI-generated custom gene editor capable of precision editing of the human genome. is just the beginning of ...